Robyn Temple-Smolkin
banner
robyntemple.bsky.social
Robyn Temple-Smolkin
@robyntemple.bsky.social
Senior Director, Clinical & Scientific Affairs; Director, Guideline Development at the Association for Molecular Pathology. MBA, PhD, HCLD(ABB). Opinions are my own; shares are not endorsements.
Reposted by Robyn Temple-Smolkin
🚨 Big news: The U.S. District Court has ruled in our favor, thwarting the FDA’s attempt to impose excessive regulations on laboratory-developed testing procedures (LDTs). This is a win for labs, patients and innovation! Read our press release: www.eurekalert.org/news-release...
March 31, 2025 at 8:57 PM
Reposted by Robyn Temple-Smolkin
Abstract submission for #AMP2025 begins in just a couple of weeks! Here's a guide to help you write a competitive abstract. Bookmark/download this PDF for future use:
amp25.amp.org/amp25/assets...

We sure hope to see you (and your work) in Boston in November!
March 19, 2025 at 10:53 PM
Happy to share I'm now an @ASAEcenter Certified Association Executive (CAE)! Congratulations to all who received their new credential today!
February 6, 2025 at 11:01 PM
Looking forward to what 2025 will bring!
December 24, 2024 at 3:46 PM
Reposted by Robyn Temple-Smolkin
Not sure what your lab should be doing in light of the FDA's final rule on laboratory-developed testing procedures? We've put together a webpage with a ton of resources to help you at each stage. Check it out and share it with others who need it: www.amp.org/advocacy...
December 13, 2024 at 1:00 PM
Thank you #AMPath24 Program Cmte, all our exhibitors & sponsors, speakers, attendees, volunteers, and the @AMPath team for another truly amazing meeting. Thank you #Vancouver for being such a wonderful host city. Save the dates now for #AMPath25 Boston! #beantown
November 24, 2024 at 2:29 PM
Beginning to discuss the clinical bioinformatician’s role in a #Molecular lab in Rm 211 #AMPath24 @roysomak4 @sabahkadri Annette Leon Weiwei Zhang Ryan Schmidt
November 22, 2024 at 9:44 PM
@AMPath Pres-elect Jane Gibson kicks off panel discussion about provider & patient-friendly molecular biomarker reporting #AMPath24 Rm 220
November 21, 2024 at 10:43 PM
On my way to #AMPath24 in Vancouver #WomeninSTEM #firstpost #science
November 18, 2024 at 11:58 AM